mci 154 has been researched along with enalapril in 1 studies
| Studies (mci 154) | Trials (mci 154) | Recent Studies (post-2010) (mci 154) | Studies (enalapril) | Trials (enalapril) | Recent Studies (post-2010) (enalapril) |
|---|---|---|---|---|---|
| 65 | 1 | 0 | 6,311 | 1,924 | 859 |
| Protein | Taxonomy | mci 154 (IC50) | enalapril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.3536 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.7083 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 1.2 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.14 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Kitada, Y; Narimatsu, A | 1 |
1 other study(ies) available for mci 154 and enalapril
| Article | Year |
|---|---|
Effect of a calcium-sensitizing positive inotropic agent MCI-154 and its combined use with enalapril on postischemic contractile dysfunction of dog hearts.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium; Cardiotonic Agents; Coronary Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Infusions, Intravenous; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Pyridazines | 1995 |